Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MGTX - MeiraGTx: Early Stage Gene Therapy Developer For Eye Diseases

MGTX - MeiraGTx: Early Stage Gene Therapy Developer For Eye Diseases

MeiraGTx Holdings plc
  • MGTX has early proof of concept data for ophthalmic rare disease indications using its gene therapies.
  • It has inked two deals with Janssen, one of them quite lucrative.
  • The company does not have a lot of cash, but its pipeline is interesting.

For further details see:

MeiraGTx: Early Stage Gene Therapy Developer For Eye Diseases
Stock Information
Company Name: MeiraGTx Holdings plc
Stock Symbol: MGTX
Market: NASDAQ
Website: meiragtx.com
Menu
MGTX MGTX Quote MGTX Short MGTX News MGTX Articles MGTX Message Board
Get MGTX Alerts

News, Short Squeeze, Breakout and More Instantly...